Biofidelity raised $24 million to enhance cancer diagnostics and advance precision medicine, aiming ...
$24M
Earli Inc. has raised $20 million in Series A funding to advance synthetic biopsy technology, aiming...
$20M
BioAffinity Technologies has secured $2.66 million in funding to advance early cancer detection and ...
$2.66M
Discover the best options tailored to your needs.
Join thousands of satisfied customers.
